Drugs / ADRC
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT06303752 | Oct 2024 → Oct 2027 expected | anal fistula | University of Southern Denmark | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ADRC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06303752 ↗ |
| Modality | Cell therapy | “30 million autologous adipose-derived regenerative cells ADRC” NCT06303752 ↗ |
| Route | Other | “receive injection of 5 ml suspension” NCT06303752 ↗ |